tanshinone has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, L; Guo, H; Hu, L; Jing, H; Liu, Z; Wang, S; Yang, H | 1 |
1 other study(ies) available for tanshinone and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Abietanes; Animals; Anti-Inflammatory Agents; Ants; Cell Line; Corpus Striatum; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Gene Expression Regulation; Male; Membrane Proteins; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Parkinsonian Disorders; Phytotherapy; Rotarod Performance Test | 2015 |